Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E-Reference-Cited by-同舟云学术

Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E

Published:2017-12 Issue:6 Volume:27 Page:585-590
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Hallmeyer Sigrun,Gonzalez Rene,Lawson David H.,Cranmer Lee D.,Linette Gerald P.,Puzanov Igor,Taback Bret,Cowey C. Lance,Ribas Antoni,Daniels Gregory A.,Moore Timothy,Gibney Geoffrey T.,Tawbi Hussein,Whitman Eric,Lee Geraldine,Mun Yong,Liu Shiyao,Hamid Omid

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference16 articles.

1. The role of BRAF V600 mutation in melanoma;Ascierto;J Transl Med,2012

2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

3. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF;Wan;Cell,2004

4. Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma;Menzies;Clin Cancer Res,2012

5. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma;Long;J Clin Oncol,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel RAF‐directed approaches to overcome current clinical limits and block the RAS/RAF node;Molecular Oncology;2024-02-16

2. Antiproliferative Imidazo-Pyrazole-Based Hydrogel: A Promising Approach for the Development of New Treatments for PLX-Resistant Melanoma;Pharmaceutics;2023-10-04

3. Editorial: Redox metabolism: a double edge sword sustaining the adaptive resistance to therapy in cancer;Frontiers in Oncology;2023-08-15

4. PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism;Frontiers in Oncology;2023-07-18

5. BRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis;Cancers;2022-12-26